Over the past two decades, outsourcing has become increasingly common in the pharmaceutical, biotechnology and agricultural industries with a transition in more recent years toward functional outsourcing where whole segments of an R&D organization are outsourced. Outsourcing of core functions including clinical trial management, manufacturing, and even entire therapeutic areas has been observed across industries. Dow AgroSciences has opted to leverage CROs within the Discovery organization involving both lead generation and lead optimization project teams in a highly integrated manner. This model creates supplemental resources for DAS scientists to utilize in the execution of ideas through direct collaboration with CRO project leaders and CRO chemists. The theory behind this strategy, logistics for execution, and metrics supporting the success of this program will be discussed.

Partnering for success with contract research organizations (CROs) to enhance discovery R&D productivity

246th National Meeting (2013)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.